{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:32:28Z","timestamp":1794897148012,"version":"4.9.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Recent findings from the REPRIEVE study suggest statins provide greater cardiovascular protection in persons with HIV (PWH) than expected from low-density lipoprotein (LDL) cholesterol reduction alone. Statins may modulate Th1-type immune responses, including interferon-gamma (IFN-\u03b3), neopterin, and kynurenine metabolism. We investigated if statin use in PWH was associated with suppression of Th1-type immune responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study included PWH from the Copenhagen Comorbidity in HIV infection (COCOMO) study. Demographic and clinical variables were collected through questionnaires and physical examinations. Plasma IFN-\u03b3, neopterin, kynurenine-to-tryptophan ratio [marker of indoleamine 2,3-dioxygenase (IDO)-1 activity], interleukin (IL)-6, IL-1\u03b2, soluble CD14, and clinical data were measured in plasma. Multivariable logistic regression models were adjusted for age, sex, waist-to-hip ratio, metabolic syndrome, physical activity, high-sensitivity C-reactive protein, and LDL cholesterol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We included 1041 of whom 130 (12.5%) received statins. Statin-treated PWH were older (60 vs. 49\u200ayears), and more frequently men (92 vs. 84%). In unadjusted analyses, odds of elevated markers of Th1 immune responses did not differ significantly between groups. After multivariable adjustment, statin exposure was associated with lower odds of high kynurenine-to-tryptophan ratio [odds ratio (OR): 0.60; 95% confidence interval (CI) 0.37\u20130.98], IFN-\u03b3 (OR 0.58; 95% CI 0.36\u20130.92), and neopterin (OR 0.58; 95% CI 0.36\u20130.92). No significant associations were observed for IL-6, IL-1\u03b2, or soluble CD14.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In PWH, statin therapy was independently associated with suppression of Th1-type immune responses. These findings support a lipid-independent, immunomodulatory mechanism by which statins may confer cardiovascular protection in HIV infection and warrant confirmation in prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/qad.0000000000004366","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:05:28Z","timestamp":1759853128000},"page":"330-335","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Inhibition of Th1-type immune responses in persons with HIV with current statin exposure"],"prefix":"10.1097","volume":"40","author":[{"given":"Andreas Dehlb\u00e6k","family":"Knudsen","sequence":"first","affiliation":[{"name":"Viro-immunology Research Unit, Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gelpi","sequence":"additional","affiliation":[{"name":"Viro-immunology Research Unit, Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises A.","family":"Suarez-Zdunek","sequence":"additional","affiliation":[{"name":"Viro-immunology Research Unit, Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefine A.","family":"Loft","sequence":"additional","affiliation":[{"name":"Viro-immunology Research Unit, Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Magne","family":"Ueland","sequence":"additional","affiliation":[{"name":"BEVITAL, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Rigshospitalet"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ivind","family":"Midttun","sequence":"additional","affiliation":[{"name":"BEVITAL, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Martinez","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic de Barcelona, Barcelona"},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Viro-immunology Research Unit, Department of Infectious Diseases 8632, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"R1-20260129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"R2-20260129","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S2352-3018(25)00047-5","article-title":"Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease","volume":"12","author":"Alagaratnam","year":"2025","journal-title":"Lancet HIV"},{"key":"R3-20260129","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/eurheartj\/ehi881","article-title":"Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for \u2018pleiotropic\u2019 functions of statin therapy","volume":"27","author":"Fichtlscherer","year":"2006","journal-title":"Eur Heart J"},{"key":"R4-20260129","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"R5-20260129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamacardio.2023.5661","article-title":"Effects of pitavastatin on coronary artery disease and inflammatory biomarkers in HIV: mechanistic substudy of the REPRIEVE randomized clinical trial","volume":"9","author":"Lu","year":"2024","journal-title":"JAMA Cardiol"},{"key":"R7-20260129","doi-asserted-by":"crossref","first-page":"1079668","DOI":"10.3389\/fimmu.2022.1079668","article-title":"The emerging role of Th1 cells in atherosclerosis and its implications for therapy","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"R8-20260129","first-page":"419","article-title":"Abdominal adipose tissue is associated with alterations in tryptophan-kynurenine metabolism and markers of systemic inflammation in people with human immunodeficiency virus","volume":"221","author":"Gelpi","year":"2020","journal-title":"J Infect Dis"},{"key":"R9-20260129","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1073\/pnas.1517820112","article-title":"Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development","volume":"112","author":"Cole","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-20260129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.2003.02021.x","article-title":"Atorvastatin suppresses interferon-\u03b3-induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines","volume":"131","author":"Neurauter","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"R11-20260129","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ejheart.2005.01.020","article-title":"Effects of atorvastatin on Th polarization in patients with acute myocardial infarction","volume":"7","author":"Cheng","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R12-20260129","doi-asserted-by":"crossref","first-page":"98215","DOI":"10.18632\/oncotarget.21003","article-title":"Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling","volume":"8","author":"Okoye","year":"2017","journal-title":"Oncotarget"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0000000000004366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:00:36Z","timestamp":1769706036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0000000000004366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0000000000004366","relation":{},"ISSN":["0269-9370","1473-5571"],"issn-type":[{"value":"0269-9370","type":"print"},{"value":"1473-5571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"2025-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}